{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:23:42Z","timestamp":1774542222967,"version":"3.50.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2000,3,1]]},"DOI":"10.1038\/sj.mp.4000650","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:50:03Z","timestamp":1031165403000},"page":"150-158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment"],"prefix":"10.1038","volume":"5","author":[{"given":"V","family":"Arolt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rothermundt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K-P","family":"Wandinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,5,15]]},"reference":[{"key":"BF4000650_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF02870716","volume":"157","author":"H Lehmann-Facius","year":"1937","unstructured":"Lehmann-Facius H . Liquoruntersuchungen bei destruktiven Erkrankungen des Nervensystems, besonders bei Schizophrenien Neurol Psychiatrie 1937; 157: 109\u2013115","journal-title":"Neurol Psychiatrie"},{"key":"BF4000650_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3109\/07853899309147317","volume":"25","author":"R Ganguli","year":"1993","unstructured":"Ganguli R, Brar JS, Chengappa KNR, Yang ZW, Nimgaonkar VL, Rabin BS . Autoimmunity in schizophrenia Ann Med 1993; 25: 489\u2013496","journal-title":"Ann Med"},{"key":"BF4000650_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0090-1229(05)80001-7","volume":"61","author":"G Kroemer","year":"1991","unstructured":"Kroemer G, Martinez C . Cytokines and autoimmune disease Clin Immunol Immunopathol 1991; 61: 275\u2013295","journal-title":"Clin Immunol Immunopathol"},{"key":"BF4000650_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2249.1992.tb06873.x","volume":"89","author":"S Ruschen","year":"1992","unstructured":"Ruschen S, Stellberg W, Warnatz H . Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid patients are different from those of healthy controls Clin Exp Immunol 1992; 89: 32\u201337","journal-title":"Clin Exp Immunol"},{"key":"BF4000650_CR5","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4049\/jimmunol.140.5.1401","volume":"140","author":"ME Sanders","year":"1988","unstructured":"Sanders ME, Makoba MW, Sharrow SO, Stephany D, Springer TA, Young HA et al. Human memory T-lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2 and LFA-1) and three other molecules (UCHL-1, Cdw29 and Pgp-1) and have enhanced interferon-gamma production J Immunol 1988; 140: 1401\u20131407","journal-title":"J Immunol"},{"key":"BF4000650_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1192\/bjp.49.207.614","volume":"49","author":"LC Bruce","year":"1903","unstructured":"Bruce LC, Peebles AMS . Clinical and experimental observations on catatonia J Ment Sci 1903; 49: 614\u2013628","journal-title":"J Ment Sci"},{"key":"BF4000650_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/schbul\/19.2.355","volume":"19","author":"DG Kirch","year":"1993","unstructured":"Kirch DG . Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal Schizophr Bull 1993; 19: 355\u2013370","journal-title":"Schizophr Bull"},{"key":"BF4000650_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1749-6632.1987.tb35828.x","volume":"469","author":"F Villemain","year":"1987","unstructured":"Villemain F, Chatenoud L, Guillibert E, Pelicier Y, Bach JF . Decreased production of interleukin-2 in schizophrenia Ann NY Acad Sci 1987; 469: 669\u2013675","journal-title":"Ann NY Acad Sci"},{"key":"BF4000650_CR9","unstructured":"Kolyaskina GI, Morozov TP, Sekirina TP, Burbayeya GS . Immunological and Virological Studies in Schizophrenia. Presented at the Second World Congress on Viruses, Immunity, and Mental Health, October 6, 1988, Quebec"},{"key":"BF4000650_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1176\/ajp.146.5.609","volume":"146","author":"F Villemain","year":"1989","unstructured":"Villemain F, Chatenoud L, Galinowski A, Homo-Delarche F, Ginestet D, Loo H et al. Aberrant T-cell mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production Am J Psychiatry 1989; 146: 609\u2013616","journal-title":"Am J Psychiatry"},{"key":"BF4000650_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0006-3223(89)90061-9","volume":"26","author":"R Ganguli","year":"1989","unstructured":"Ganguli R, Rabin BS, Belle SH . Decreased interleukin-2 production in schizophrenic patients Biol Psychiatry 1989; 26: 427\u2013430","journal-title":"Biol Psychiatry"},{"key":"BF4000650_CR12","doi-asserted-by":"publisher","first-page":"173A","DOI":"10.1016\/0006-3223(90)90041-Y","volume":"27","author":"P Sirota","year":"1990","unstructured":"Sirota P, Fishman P, Elizur A, Djaldetty M . Lymphokine production in schizophrenic patients Biol Psychiatry 1990; 27: 173A","journal-title":"Biol Psychiatry"},{"key":"BF4000650_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0006-3223(94)00299-I","volume":"38","author":"H Bessler","year":"1995","unstructured":"Bessler H, Levental Z, Karp L, Modai I, Djaldetti M, Weizman A . Cytokine production in drug-free and neuroleptic-treated schizophrenic patients Biol Psychiatry 1995; 38: 297\u2013302","journal-title":"Biol Psychiatry"},{"key":"BF4000650_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0920-9964(94)00046-B","volume":"15","author":"M Hornberg","year":"1995","unstructured":"Hornberg M, Arolt V, Wilke I, Kruse A, Kirchner H . Lymphokine production in leukocyte cultures of patients with schizophrenia Schizophr Res 1995; 15: 237\u2013242","journal-title":"Schizophr Res"},{"key":"BF4000650_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF02190280","volume":"246","author":"I Wilke","year":"1996","unstructured":"Wilke I, Arolt V, Hornberg M, Kirchner H . Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenics Eur Arch Psychiatry Clin Neurosci 1996; 246: 279\u2013284","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"BF4000650_CR16","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1176\/ajp.150.9.1408","volume":"150","author":"J Licinio","year":"1993","unstructured":"Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH . Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients Am J Psychiatry 1993; 150: 1408\u20131410","journal-title":"Am J Psychiatry"},{"key":"BF4000650_CR17","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1176\/ajp.152.9.1291","volume":"152","author":"CG McAllister","year":"1995","unstructured":"McAllister CG, van Kammen DP, Rehn TJ, Miller AL, Gurklis J, Kelley ME et al. Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status Am J Psychiatry 1995; 152: 1291\u20131297","journal-title":"Am J Psychiatry"},{"key":"BF4000650_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/archpsyc.1989.01810030098018","volume":"46","author":"R Ganguli","year":"1989","unstructured":"Ganguli R, Rabin BS . Increased serum interleukin-2 receptor in schizophrenic and brain damaged subjects Arch Gen Psychiatry 1989; 46: 292","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000650_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/archpsyc.1989.01810030097017","volume":"46","author":"MH Rapaport","year":"1989","unstructured":"Rapaport MH, McAllister CG, Pickar D, Nelson DL, Paul SM . Elevated levels of soluble interleukin-2 receptors in schizophrenia Arch Gen Psychiatry 1989; 46: 291\u2013292","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000650_CR20","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1176\/ajp.142.10.1184","volume":"142","author":"OT Preble","year":"1985","unstructured":"Preble OT, Torrey EF . Serum interferon in patients with psychosis Am J Psychiatry 1985; 142: 1184\u20131186","journal-title":"Am J Psychiatry"},{"key":"BF4000650_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1600-0447.1986.tb02739.x","volume":"73","author":"L Schindler","year":"1986","unstructured":"Schindler L, Leroux M, Beck J, Moises HW, Kirchner H . Studies of cellular immunity, serum interferon titers, and natural killer cell activity in schizophrenic patients Acta Psychiatr Scand 1986; 73: 651\u2013657","journal-title":"Acta Psychiatr Scand"},{"key":"BF4000650_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1192\/bjp.157.1.136","volume":"157","author":"D Becker","year":"1990","unstructured":"Becker D, Kritschmann E, Floru S, Shlomo-David Y, Gotlieb-Stematsky T . Serum interferon in first psychotic attack Br J Psychiatry 1990; 157: 136\u2013138","journal-title":"Br J Psychiatry"},{"key":"BF4000650_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0920-9964(92)90006-Q","volume":"6","author":"WF Gattaz","year":"1992","unstructured":"Gattaz WF, Dalgalarrondo P, Schr\u00f6der HC . Abnormalities in serum concentrations of interleukin-2 and interferon-\u03b3 in schizophrenia not detected Schizophr Res 1992; 6: 237\u2013241","journal-title":"Schizophr Res"},{"key":"BF4000650_CR24","first-page":"194","volume":"48","author":"A Ahokas","year":"1987","unstructured":"Ahokas A, Rimon R, Koskemieni M, Vaheri A, Julkunen I, Sarna S . Viral antibodies and interferon in acute psychiatric disorders J Clin Psychiatry 1987; 48: 194\u2013196","journal-title":"J Clin Psychiatry"},{"key":"BF4000650_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0920-9964(89)90028-5","volume":"2","author":"H Katila","year":"1989","unstructured":"Katila H, Cantell K, Hirvonen S, Rimon R . Production of interferon alpha and gamma by lymphocytes from patients with schizophrenia Schizophr Res 1989; 2: 361\u2013365","journal-title":"Schizophr Res"},{"key":"BF4000650_CR26","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S0278-5846(98)00059-1","volume":"22","author":"CL Cazzullo","year":"1998","unstructured":"Cazzullo CL, Scarone S, Grassi B, Vismara C, Trabattoni D, Clerici M et al. Cytokines production in chronic schizophrenia patients with or without paranoid behaviour Prog Neuropsychopharmacol Biol Psychiatry 1998; 22: 947\u2013957","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BF4000650_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-0447.1985.tb02569.x","volume":"72","author":"HW Moises","year":"1985","unstructured":"Moises HW, Schindler L, Leroux M, Kirchner H . Decreased production of interferon-gamma in leucocyte cultures of schizophrenic patients Acta Psychiat Scand 1985; 72: 45\u201350","journal-title":"Acta Psychiat Scand"},{"key":"BF4000650_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0022-1759(82)90195-8","volume":"48","author":"H Kirchner","year":"1982","unstructured":"Kirchner H, Kleinicke C, Diegel W . A whole blood technique for testing production of human interferon by leukocytes Immunol Meth 1982; 48: 213\u2013219","journal-title":"Immunol Meth"},{"key":"BF4000650_CR29","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/S0006-3223(96)00360-5","volume":"40","author":"M Rothermundt","year":"1996","unstructured":"Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H . Production of cytokines in acute schizophrenic psychosis Biol Psychiatry 1996; 40: 1294\u20131297","journal-title":"Biol Psychiatry"},{"key":"BF4000650_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0165-1781(96)03023-5","volume":"66","author":"V Arolt","year":"1997","unstructured":"Arolt V, Weitzsch C, Wilke I, Nolte A, Pinnow M, Kirchner H . Production of interferon-gamma in families with multiple occurrence of schizophrenia Psychiatry Res 1997; 66: 145\u2013151","journal-title":"Psychiatry Res"},{"key":"BF4000650_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000058636","volume":"18","author":"V Arolt","year":"1997","unstructured":"Arolt V, Weitzsch C . Rothermundt M, Eckhoff D, Kirchner H. Interferon-gamma in schizophrenia Adv Biol Psychiatry 1997; 18: 57\u201366","journal-title":"Adv Biol Psychiatry"},{"key":"BF4000650_CR32","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR . The Brief Psychiatric Rating Scale Psychol Rep 1962; 10: 799\u2013812","journal-title":"Psychol Rep"},{"key":"BF4000650_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fishbein A, Oppler LA . The Positive and Negative Syndrom Scale (PANSS) for schizophrenia Schizophr Bull 1987; 13: 261\u2013276","journal-title":"Schizophr Bull"},{"key":"BF4000650_CR34","doi-asserted-by":"publisher","first-page":"552","DOI":"10.2337\/diab.33.6.552","volume":"33","author":"KS Zier","year":"1984","unstructured":"Zier KS, Leo MM, Spielman RS, Baker L . Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus Diabetes 1984; 33: 552\u2013555","journal-title":"Diabetes"},{"key":"BF4000650_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0090-1229(88)90094-3","volume":"49","author":"MG Roncarolo","year":"1988","unstructured":"Roncarolo MG, Zoppo M, Bacchetta R, Gabbiano C, Sacchetti C, Cerutti F et al. Interleukin-2 production and interleukin-2 receptor expression in children with newly diagnosed diabetes Clin Immunol Immunopathol 1988; 49: 53\u201362","journal-title":"Clin Immunol Immunopathol"},{"key":"BF4000650_CR36","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1056\/NEJM198610093151502","volume":"315","author":"WA Kaye","year":"1986","unstructured":"Kaye WA, Adri MN, Soeldner JS, Rabinowe SL, Kaldany A, Kahn CR et al. Aquired defect of interleukin-2 production in patients with type I diabetes mellitus N Engl J Med 1986; 315: 920\u2013924","journal-title":"N Engl J Med"},{"key":"BF4000650_CR37","first-page":"482","volume":"5","author":"GB Catheley","year":"1986","unstructured":"Catheley GB, Amor B, Fournier C . Defective IL-2 production in active rheumatoid arthritis: regulation by radiosensitive suppressor cells Clin Rheumatol 1986; 5: 482\u2013492","journal-title":"Clin Rheumatol"},{"key":"BF4000650_CR38","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/rheumatology\/32.7.550","volume":"32","author":"EI Jokinen","year":"1993","unstructured":"Jokinen EI, Mottonen TT, Hannonen PJ, Arvilommi HS . Association of in vitro immune functions with the severity of the disease in rheumatoid arthritis Br J Rheumatol 1993; 32: 550\u2013555","journal-title":"Br J Rheumatol"},{"key":"BF4000650_CR39","first-page":"406","volume":"22","author":"G Steiner","year":"1995","unstructured":"Steiner G, Studnicka-Benke A, Witzmann G, Hofler E, Smolen J . Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis J Rheumatol 1995; 22: 406\u2013412","journal-title":"J Rheumatol"},{"key":"BF4000650_CR40","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/096120339300200113","volume":"2","author":"MJ Cuadrado","year":"1993","unstructured":"Cuadrado MJ, Marubayashi M, Ortega C, Fernandez-Arcas N, Garcia-Cozar F, Pena J et al. Relationship of IL-2, IL-2R (CD25+), soluble IL-2R, and IL-4 with disease activity in SLE patients Lupus 1993; 2: 257\u2013260","journal-title":"Lupus"},{"key":"BF4000650_CR41","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3109\/08923979309019728","volume":"15","author":"EJ Kucharz","year":"1993","unstructured":"Kucharz EJ, Sierakowski SJ, Goodwin JS . Lithium in vitro enhances interleukin-2 production by T cells from patients with systemic lupus erythematosus Immunopharmacol Immunotoxicol 1993; 15: 515\u2013523","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"BF4000650_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/096120339500400107","volume":"4","author":"MY Samosonov","year":"1995","unstructured":"Samosonov MY, Tilz GP, Egorova O, Reibnegger G, Balabanova RM, Nassonov EL et al. Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus Lupus 1995; 4: 29\u201332","journal-title":"Lupus"},{"key":"BF4000650_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-2249.1995.tb05541.x","volume":"99","author":"T Suzuki","year":"1995","unstructured":"Suzuki T, Suzuki N, Engleman EG, Mitsushima Y, Sakane T . Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus Clin Exp Immunol 1995; 99: 251\u2013255","journal-title":"Clin Exp Immunol"},{"key":"BF4000650_CR44","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/(SICI)1097-0320(19970615)30:3<118::AID-CYTO2>3.0.CO;2-H","volume":"30","author":"JJ Corrales","year":"1997","unstructured":"Corrales JJ, Orfao A, Lopez A, Mories MT, Miralles JM, Ciudad J . Analysis of IL-2 and IL-6 binding to peripheral blood lymphocytes in Graves\u2019 disease. Relationship with disease activity Cytometr 1997; 30: 118\u2013123","journal-title":"Cytometr"},{"key":"BF4000650_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2249.1994.tb06561.x","volume":"96","author":"Z Eisenstein","year":"1994","unstructured":"Eisenstein Z, Engelsman E, Weiss M, Kalechman Y, Sredni B . Modulation of the IL-2 production defect in vitro in Graves\u2019 disease Clin Exp Immunol 1994; 96: 323\u2013328","journal-title":"Clin Exp Immunol"},{"key":"BF4000650_CR46","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/(SICI)1097-4547(19960815)45:4<322::AID-JNR1>3.0.CO;2-B","volume":"45","author":"V Navikas","year":"1996","unstructured":"Navikas V, Link H . Review: cytokines and the pathogenesis of multiple sclerosis J Neurosci Res 1996; 45: 322\u2013333","journal-title":"J Neurosci Res"},{"key":"BF4000650_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0022-510X(88)90036-6","volume":"85","author":"K Selmaj","year":"1988","unstructured":"Selmaj K, Nowak Z, Tchorzewski H . Interleukin-1 and interleukin-2 production by peripheral blood mononuclear cells in multiple sclerosis patients J Neurol Sci 1988; 85: 67\u201376","journal-title":"J Neurol Sci"},{"key":"BF4000650_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0022-510X(97)05383-5","volume":"149","author":"KP Wandinger","year":"1997","unstructured":"Wandinger KP, Wessel K, Neustock P, Siekhaus A, Kirchner H . Diminished production of type I interferon and interleukin-2 in patients with multiple sclerosis J Neurol Sci 1997; 149: 87\u201393","journal-title":"J Neurol Sci"},{"key":"BF4000650_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ana.410300110","volume":"30","author":"HP Hartung","year":"1991","unstructured":"Hartung HP, Reiners K, Schmidt B, Stoll G, Toyka KV . Serum interleukin-2 concentrations in Guillain-Barr\u00e9 syndrome and chronic ideopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis Ann Neurol 1991; 30: 48\u201353","journal-title":"Ann Neurol"},{"key":"BF4000650_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/brain\/117.2.307","volume":"117","author":"Y Zoukos","year":"1994","unstructured":"Zoukos Y, Kidd D, Woodroofe MN, Kendall BE, Thompsom AJ, Cuzner ML . Increased expression of high affinity IL-2 receptors and beta-adrenoreceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis Brain 1994; 117: 307\u2013315","journal-title":"Brain"},{"key":"BF4000650_CR51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0168-8227(93)90054-9","volume":"21","author":"A Ciampolillo","year":"1993","unstructured":"Ciampolillo A, Guastamachia E, Caragiulo L, Lollino G, DeRobertis O, Lattanzi V et al. In vitro secretion of interleukin-1 beta and interferon-gamma by peripheral blood lymphomononuclear cells in diabetic patients Diabetes Res Clin Prac 1993; 21: 87\u201393","journal-title":"Diabetes Res Clin Prac"},{"key":"BF4000650_CR52","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1084\/jem.185.3.531","volume":"185","author":"MG Vonherrath","year":"1997","unstructured":"Vonherrath MG, Oldstone MBA . Interferon gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus J Exp Med 1997; 185: 531\u2013539","journal-title":"J Exp Med"},{"key":"BF4000650_CR53","doi-asserted-by":"publisher","first-page":"770","DOI":"10.2337\/diab.46.5.770","volume":"46","author":"ME Baldeon","year":"1997","unstructured":"Baldeon ME, Neece DJ, Nandi D, Monaco JJ, Gaskins HR . Interferon gamma independently activates the MHC class I antigen processing pathway and diminishes glucose responsiveness in pancreatic cell lines Diabetes 1997; 46: 770\u2013778","journal-title":"Diabetes"},{"key":"BF4000650_CR54","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/1043-4666(92)90021-I","volume":"4","author":"PF Zangerle","year":"1992","unstructured":"Zangerle PF, DeGroote D, Lopez M, Meuleman RJ, Vrindts Y, Fauchet F et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma, and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis Cytokine 1992; 4: 568\u2013575","journal-title":"Cytokine"},{"key":"BF4000650_CR55","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1046\/j.1365-2249.1997.4331330.x","volume":"109","author":"M Gattorno","year":"1997","unstructured":"Gattorno M, Facchetti P, Ghiotto F, Vignola S, Buoncompagni A, Prigione I et al. Synovial fluid T cell clones from oligoarthricular juvenile arthritis patients display a prevalent TH1\/TH0-type pattern of cytokine secretion irrespective of immunophenotype Clin Exp Immunol 1997; 109: 4\u201311","journal-title":"Clin Exp Immunol"},{"key":"BF4000650_CR56","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/art.1780391204","volume":"39","author":"RJEM Dolhain","year":"1996","unstructured":"Dolhain RJEM, Vanderheiden AN, Terhaar NT, Breedveld FC, Miltenburg AMM . Shift towards T-lymphocytes with a T-helper1 cytokine secretion profile in the joints of patients with rheumatoid arthritis Arthritis Rheumatism 1996; 39: 1961\u20131969","journal-title":"Arthritis Rheumatism"},{"issue":"suppl 6","key":"BF4000650_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1212\/WNL.45.6_Suppl_6.S11","volume":"45","author":"T Olsson","year":"1995","unstructured":"Olsson T . Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis Neurology 1995; 45: (suppl 6) 11\u201315","journal-title":"Neurology"},{"key":"BF4000650_CR58","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1600-0404.1988.tb03663.x","volume":"78","author":"J Beck","year":"1988","unstructured":"Beck J, Rondot P, Catinot L, Falcoff L, Kirchner H, Wietzerbin J . Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 1988; 78: 318\u2013323","journal-title":"Acta Neurol Scand"},{"key":"BF4000650_CR59","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1096\/fasebj.9.8.7768352","volume":"9","author":"J Merrill","year":"1995","unstructured":"Merrill J, Jonakait GM . Interactions of the nervous and immune systems in development, normal brain homeostasis, and disease FASEB J 1995; 9: 611\u2013618","journal-title":"FASEB J"},{"key":"BF4000650_CR60","first-page":"1149","volume":"12","author":"GM Jonakait","year":"1995","unstructured":"Jonakait GM . Interferon-gamma promotes cholinergic differentiation of embrionic septal nuclei and adjacent basal forebrain Neuron 1995; 12: 1149\u20131159","journal-title":"Neuron"},{"key":"BF4000650_CR61","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0166-2236(91)90086-A","volume":"14","author":"G Nistico","year":"1991","unstructured":"Nistico G, DeSarro G . Is interleukin-2 a neuromodulator in the brain? Trends Neurosci 1991; 14: 146\u2013150","journal-title":"Trends Neurosci"},{"key":"BF4000650_CR62","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/j.1471-4159.1993.tb13620.x","volume":"61","author":"R Alonso","year":"1993","unstructured":"Alonso R, Chaudieu I, Diorio J, Krishnamurthy A, Quirion R, Boksa P . Interleukin-2 modulates evoked release of 3H-dopamine in rat cultured mesencephalic cells J Neurochem 1993; 61: 1284\u20131290","journal-title":"J Neurochem"},{"key":"BF4000650_CR63","first-page":"165","volume":"3","author":"PA Lapchak","year":"1992","unstructured":"Lapchak PA . A role for interleukin-2 in the regulation of striatal dopaminergic function Neuro Report 1992; 3: 165\u2013168","journal-title":"Neuro Report"},{"key":"BF4000650_CR64","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/sj.mp.4000426","volume":"3","author":"KI Pasternak","year":"1998","unstructured":"Pasternak KI, Timo-Iara C, Rodrigues CJ, Maria DA, Duarte AJS, Paiva L et al. Circumscribed lesion of the medial forebrain bundle area causes structural impairment of lymphoid organs and severe depression of immune function in rats Mol Psychiatry 1998; 3: 397\u2013404","journal-title":"Mol Psychiatry"},{"key":"BF4000650_CR65","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0165-2478(92)90045-P","volume":"33","author":"E Claret","year":"1992","unstructured":"Claret E, Renversez J-C, Zheng X, Bonnefoix T, Sotto J-J . Valid estimation of IL-2 secretion by PHA-stimulated T-cell clones absolutely requires the use of anti-CD25 monoclonal antibody to prevent IL-2 consumption Immunol Lett 1992; 33: 179\u2013186","journal-title":"Immunol Lett"},{"key":"BF4000650_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/BF02191517","volume":"242","author":"MH Rapaport","year":"1993","unstructured":"Rapaport MH, Torrey EF, McAllister CG, Nelson DL, Pickar D, Paul SM . Increased serum interleukin-2 receptors in schizophrenic monozygotic twins Eur Arch Psychiatr Clin Neurosci 1993; 242: 7\u201310","journal-title":"Eur Arch Psychiatr Clin Neurosci"},{"key":"BF4000650_CR67","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/archpsyc.1995.03950200058014","volume":"52","author":"R Ganguli","year":"1995","unstructured":"Ganguli R, Brar JS, Chengappa KNR, DeLeo M, Yang ZW, Shurin G et al. Mitogen-stimulated interleukin-2 production in never-medicated, first episode schizophrenic patients Arch Gen Psychiatry 1995; 52: 668\u2013671","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000650_CR68","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000026501","volume":"37","author":"M Rothermundt","year":"1998","unstructured":"Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H . Immunological dysfunction in schizophrenia: a systematic approach Neuropsychobiology 1998; 37: 186\u2013193","journal-title":"Neuropsychobiology"},{"key":"BF4000650_CR69","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1001\/archpsyc.1989.01810100098019","volume":"46","author":"CG McAllister","year":"1989","unstructured":"McAllister CG . Rapaport MH, Pickar D, Paul SM. Effects of short-term administration of antipsychotic drugs on lymphocite subsets in schizophrenic patients Arch Gen Psychiatry 1989; 46: 956\u2013957","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000650_CR70","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0165-1781(91)90072-W","volume":"37","author":"N M\u00fcller","year":"1991","unstructured":"M\u00fcller N, Ackenheil M, Hofschuster E, Mempel W, Eckstein R . Cellular immunity in schizophrenic patients before and during neuroleptic treatment Psychiatry Res 1991; 37: 147\u2013160","journal-title":"Psychiatry Res"},{"key":"BF4000650_CR71","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1600-0447.1994.tb01599.x","volume":"90","author":"MH Rapaport","year":"1994","unstructured":"Rapaport MH, Lohr JB . Serum soluble interleukin-2 receptors in neuroleptic naive schizophrenic subjects and in medicated subjects with and without tardive dyskinesia Psychiatr Scand 1994; 90: 311\u2013315","journal-title":"Psychiatr Scand"},{"key":"BF4000650_CR72","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0162-3109(97)00037-4","volume":"37","author":"I Leykin","year":"1997","unstructured":"Leykin I, Mayer R, Shinitzky M . Short and long-term immunosuppressive effects of clozapine and haloperidol Immunopharmacology 1997; 37: 75\u201386","journal-title":"Immunopharmacology"},{"key":"BF4000650_CR73","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0893-133X(98)00006-2","volume":"19","author":"D Hinze-Selch","year":"1998","unstructured":"Hinze-Selch D, Becker EW, Stein GM, Berg PA, Mullington J, Holsboer F et al. Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients Neuropsychopharmacology 1998; 19: 114\u2013122","journal-title":"Neuropsychopharmacology"},{"key":"BF4000650_CR74","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1001\/archpsyc.1995.03950220087016","volume":"52","author":"T Pollm\u00e4cher","year":"1995","unstructured":"Pollm\u00e4cher T, Hinze-Selch D, Mullington J, Holsboer F . Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors (letter) Arch Gen Psychiatry 1995; 52: 877","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000650_CR75","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/archpsyc.1995.03950220088017","volume":"52","author":"R Ganguli","year":"1995","unstructured":"Ganguli R, Brar JS, Rabin BS . Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors (comment) Arch Gen Psychiatry 1995; 52: 878","journal-title":"Arch Gen Psychiatry"},{"key":"BF4000650_CR76","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0006-3223(94)91149-5","volume":"35","author":"T Sasaki","year":"1994","unstructured":"Sasaki T, Nanko S, Fukuda R, Kawate T, Kunugi H, Kazamatsuri H . Changes of immunological functions after acute exacerbation in schizophrenia Biol Psychiatry 1994; 35: 173\u2013178","journal-title":"Biol Psychiatry"},{"key":"BF4000650_CR77","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF02190343","volume":"242","author":"S Gudewill","year":"1992","unstructured":"Gudewill S, Pollmacher T, Vedder H, Schreiber W, Fassbender K, Holsboer F . Nocturnal plasma levels of cytokines in healthy men Eur Arch Psychiatry Clin Neurosci 1992; 242: 53\u201356","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"BF4000650_CR78","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00006842-199503000-00001","volume":"57","author":"D Uthgenannt","year":"1995","unstructured":"Uthgenannt D, Schoolmann D, Pietrowsky R, Fehm HL, Born J . Effects of sleep on the production of cytokines in humans Psychosom Med 1995; 57: 97\u2013104","journal-title":"Psychosom Med"},{"key":"BF4000650_CR79","first-page":"1979","volume":"84","author":"M Irwin","year":"1999","unstructured":"Irwin M, Thompson J, Miller C, Gillin JC, Ziegler M . Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications J Clin Endocrinol Metab 1999; 84: 1979\u20131985","journal-title":"J Clin Endocrinol Metab"},{"key":"BF4000650_CR80","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/00006842-199709000-00010","volume":"59","author":"B Appelberg","year":"1997","unstructured":"Appelberg B, Katila H, Rimon R . Plasma interleukin-1 beta and sleep architecture in schizophrenia and other nonaffective psychoses Psychosom Med 1997; 59: 529\u2013532","journal-title":"Psychosom Med"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4000650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4000650","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4000650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:45:44Z","timestamp":1682037944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4000650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,1]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,3,1]]}},"alternative-id":["BF4000650"],"URL":"https:\/\/doi.org\/10.1038\/sj.mp.4000650","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3,1]]},"assertion":[{"value":"27 April 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 1999","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 1999","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2000","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}